X

Pharmacometrics & Pharmacokinetics (PMK) Community

The Pharmacometrics & Pharmacokinetics (PMK) Community represents a diverse group of scientists from pharmaceutical industry, government, and academia who are interested in the science of clinical pharmacology, pharmacokinetics/pharmacodynamics (PK/PD) and pharmacometrics as disciplines to spur the research and development of safe and effective therapeutics.

The mission of the PMK Community is to promote interaction and knowledge sharing of novel application of clinical pharmacology, PK/PD and pharmacometric approaches that can be utilized to accelerate drug discovery and development of innovative new medicines. We accomplish our mission by:
  • Education: Educational and knowledge sharing platforms on trending topics (e.g., new modalities, advanced analytics, real-world data, etc.) in clinical pharmacology, PK/PD and pharmacometrics via ASCPT’s Annual Meeting and webinars. This helps to enhance and accelerate the decision making in drug development.
  • Engagement: Promoting the engagement of Community members through collaboration, volunteer, and outreach opportunities. These efforts stimulate the connection among diverse PMK members and further grow the PMK Community.
  • Collaboration: Stimulating collaboration between the PMK Community and other ASCPT Communities (e.g., Regulatory Science, Biologics, Oncology) to advance the field of pharmacometrics, PK/PD and clinical pharmacology.

Join the LinkedIn Group.


Upcoming Webinar
ASCPT Pharmacometrics & Pharmacokinetics (PMK) Community Members-Only Webinar
Title: Marrying Real-World Data and Modeling: A Case of Interdisciplinary MIDD to Address Changes of Bone Mineral Density in Premenopausal Women
Date and Time: Monday, May 24, 2021, 2:00 pm EST
Speaker: Mohamad Shebley, PhD
Moderators: Neeraj Gupta, PhD, and Akshanth Polepally, PhD
Description: This webinar will introduce the concept of interdisciplinary model-informed drug development (i-MIDD) in a real drug development setting. The presented work will describe how real-world data (RWD) could be linked to traditional pharmaco-statistical modeling to bridge understanding of long-term bone safety in premenopausal women. The work will highlight how the RWD could be extended to epidemiological modeling for evaluating clinical relevance of the projected changes in bone mineral density (BMD) in relation to future risk of bone fractures. For additional information, please click the registration link below.
Register Now!

Past Webinars

N Gupta

Neeraj Gupta, PhD

Community Chair

 

Q Liu

Qi Liu, PhD

Community Vice Chair

 

Chunze Li, PhD

Community Past Chair

 

Steering Committee

Chunze Li, PhD (Committee Chair)
Neeraj Gupta, PhD (Committee Vice Chair)
Xiaoying Chen, PhD
Robert Bies, PhD
Bilal AbuAsal, PhD
Akshanth Polepally, PhD
Nadia Terranova, PhD
Sagar Bachhav, PhD
Photo Gallery
Recent News
Contact Us